PANGEN BIOTECH INC.

Highlights PanGen Biotech Inc.

Equities

A222110

KR7222110009

End-of-day quote Korea S.E. Other stock markets 03:30:00 31/05/2024 am IST			5-day change	1st Jan Change
6,000 ^KRW	-0.83%		+8.30%	-12.79%

27/03	PanGen Biotech Inc. announced that it has received KRW 3.999986631 billion in funding from CrystalGenomics Invites Co., LTD., Huons Co., Ltd., Hwail Pharmaceutical Co.,Ltd.	CI
18/03	PanGen Biotech Inc. announced that it expects to receive KRW 3.999986631 billion in funding from CrystalGenomics Invites Co., LTD., Huons Co., Ltd., Hwail Pharmaceutical Co.,Ltd.	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

PanGen Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/23/12	CI
CrystalGenomics, Inc. agreed to acquire 20.43% stake in PanGen Biotech Inc. from the group of shareholders for approximately KRW24 billion.	22/22/22	CI
Huons Lab Forms Partnership with Pangen Biotech to Co-Develop Human Genetic Recombinant Hyaluronidase	16/19/16	CI
CCM Duopharma Biotech Berhad completed the acquisition of 8.4% stake in PanGen Biotech Inc. from Chemical Company of Malaysia Berhad.	29/18/29	CI
CCM Duopharma Biotech Berhad entered into agreement to acquire PanGen Biotech Inc. from Chemical Company of Malaysia Berhad for KRW 16.4 billion.	13/18/13	CI
Chemical Companies In Talks To Sell Non Core Assets	02/18/02	CI
PanGen Biotech Inc. has completed an IPO in the amount of KRW 27.23 billion.	09/16/09	CI
PanGen Biotech Inc. has filed an IPO in the amount of KRW 18.75 billion.	22/16/22	CI
PanGen Biotech Inc. has withdrawn its IPO in the amount of KRW 35.40 billion.	24/15/24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer